Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (990) Arrow Down
Filter Results: (990) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)
← Page 23 of 990 Results →

    Satish K. Tadikonda

    Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School. In the MBA program, Satish teaches The Entrepreneurial Manager, a required first-year MBA course, and Entrepreneurship in Life Sciences, an elective course for... View Details

    • Article

    How to Avoid Executive Stress

    By: Thomas J. DeLong
    When teaching various groups of executives, the author relates the story of a man addicted to prescription drugs and his brother who is addicted to achievement. Each group relates to these two professionally successful men and sees that they live largely on the edge of... View Details
    Keywords: Behavior; Personal Development and Career; Personal Characteristics; Emotions
    Citation
    Related
    DeLong, Thomas J. "How to Avoid Executive Stress." Market Leader (Second Quarter 2012), 50–52.
    • 14 Nov 2017
    • First Look

    New Research and Ideas: November 14, 2017

    authors provide numerous examples of health care organizations that are taking these steps—and seeing impressive results. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53460 forthcoming JAMA Cardiology The Central and Unacknowledged Role of the U.S.... View Details
    Keywords: Carmen Nobel
    • March 1992
    • Case

    Amgen, Inc.: Planning the Unplannable

    By: Nitin Nohria
    By the early 1990s, Amgen--a pharmaceutical company started little over a decade ago as Applied Molecular Genetics--was within range of becoming a billion-dollar company. With two extremely successful biotechnology drugs on the market, Amgen stood as the largest and... View Details
    Keywords: Growth and Development Strategy; Strategic Planning; Success; Risk and Uncertainty; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Nohria, Nitin. "Amgen, Inc.: Planning the Unplannable." Harvard Business School Case 492-052, March 1992.
    • May 2023 (Revised June 2023)
    • Supplement

    Novartis (C): Reimagining Medicine

    By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
    This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
    Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
    Citation
    Related
    Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
    • Web

    Overview | MBA

    uncertainties in affecting these opportunities. Develop approaches to ethical dilemmas bedeviling novel therapeutics, including investment in neglected diseases, the provision of life-saving drugs to disadvantaged patients and those in... View Details
    • Research Summary

    Overview

    Professor Goh’s primary research interest is applying mathematical models to real-world problems in health care in order to inform, improve, and enhance medical decision making and health policy. His recent work in this domain focuses on developing new methods for... View Details
    Keywords: Uncertainty; Optimization; Inventory Management; Health; Decision Making; Supply Chain
    • February 2019 (Revised July 2019)
    • Case

    Sales Force Management at Nobel Ilac

    By: Doug J. Chung and Gamze Yucaoglu
    Nobel Ilac was a Turkish generic pharmaceutical company marketing more than 100 drugs in 20 countries and, as of 2017, had over 2,500 employees worldwide. Nobel had implemented a transformation strategy—more specifically, a customer segmentation plan—whereby the sales... View Details
    Keywords: Sales Strategy; Compensation; Employee Retention; Recruiting; Pharmaceuticals; Salesforce Management; Strategy; Organizational Design; Human Resources; Compensation and Benefits; Employees; Retention; Recruitment; Pharmaceutical Industry; Turkey
    Citation
    Educators
    Purchase
    Related
    Chung, Doug J., and Gamze Yucaoglu. "Sales Force Management at Nobel Ilac." Harvard Business School Case 519-067, February 2019. (Revised July 2019.)
    • Web

    MS/MBA Biotechnology: Life Sciences | MBA

    new drug discoveries and therapeutics. The program is completed over two academic years, utilizing January terms and time in August at the start of the program. The curriculum emphasizes developing effective business models in the... View Details
    • May 2023 (Revised June 2023)
    • Case

    Novartis (A): Reimagining Medicine

    By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
    This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
    Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
    Citation
    Educators
    Related
    Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
    • July 2024 (Revised July 2024)
    • Case

    Gates Ventures: Making Alzheimer's a Forgotten Past

    By: Satish Tadikonda, William Marks, Shardule Shah and Calvin Marambo
    After a personal journey and interest in Alzheimer's Disease (AD) by Bill Gates, Gates Ventures set out to find the best way to accelerate innovation in the field of AD. In partnership with the Alzheimer's Drug Discovery Foundation, Gates Ventures created the... View Details
    Keywords: Philanthropy and Charitable Giving; Entrepreneurial Finance; Health Disorders; Mission and Purpose
    Citation
    Educators
    Purchase
    Related
    Tadikonda, Satish, William Marks, Shardule Shah, and Calvin Marambo. "Gates Ventures: Making Alzheimer's a Forgotten Past." Harvard Business School Case 824-075, July 2024. (Revised July 2024.)
    • Web

    Faculty & Advisors | MBA

    Underscore VC, she invested in fast growing B2B software startups, including life sciences tech products used by leading biopharma companies across the drug development cycle from R&D to commercial stages. She began her career at Michael... View Details
    • January 2021
    • Case

    Value-Based Insurance Design at Onex

    By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
    The operating executives of Health and Benefits for Onex Partners, Megan Jackson Frye and Sam Camens, faced a challenge: Healthcare costs for employees of Onex’s portfolio companies were continuing to rise above the consumer price index, reflecting broader trends... View Details
    Keywords: Decision Making; Cost vs Benefits; Decision Choices and Conditions; Decisions; Finance; Behavioral Finance; Insurance; Health; Health Care and Treatment; Human Resources; Compensation and Benefits; Markets; Demand and Consumers; Consumer Behavior; Social Psychology; Behavior; Interests; Motivation and Incentives; Perception; Health Industry; Insurance Industry; North America; United States
    Citation
    Educators
    Purchase
    Related
    Schwartzstein, Joshua, Amitabh Chandra, and Amram Migdal. "Value-Based Insurance Design at Onex." Harvard Business School Case 921-023, January 2021.
    • 21 Aug 2007
    • First Look

    First Look: August 21, 2007

    http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807074   PublicationsPerspectives on Risk and Regulation: The FDA at 100 Author:Arthur A. Daemmrich Publication:Chemical Heritage Press, 2007 Abstract Perspectives on Risk and Regulation: The FDA at 100... View Details
    Keywords: Martha Lagace
    • February 2022 (Revised September 2022)
    • Case

    InstaDeep: AI Innovation Born in Africa (A)

    By: Shikhar Ghosh and Esel Çekin
    Karim Beguir and Zohra Slim were the co-founders of InstaDeep, a deep tech startup focusing on artificial intelligence (AI) solutions. Instadeep was one of the few companies globally that were partnering with DeepMind, an AI subsidiary of Google [Alphabet Inc.].... View Details
    Keywords: AI; Artificial Intelligence; Entrepreneurship; Operations; Business Subsidiaries; Brands and Branding; Innovation and Invention; Growth and Development Strategy; AI and Machine Learning; Technology Industry; Africa
    Citation
    Educators
    Purchase
    Related
    Ghosh, Shikhar, and Esel Çekin. "InstaDeep: AI Innovation Born in Africa (A)." Harvard Business School Case 822-104, February 2022. (Revised September 2022.)
    • September 2023 (Revised April 2024)
    • Case

    Atomwise: Strategic Opportunities in AI for Pharma

    By: Satish Tadikonda
    Abraham Heifets and his co-founder, Izhar Wallach, had founded Atomwise to develop i) an AI engine to transform drug discovery by creating better medicines faster, and ii) a machine learning-based discovery engine that combined the power of convolutional neural... View Details
    Keywords: Business Model; Business Startups; AI and Machine Learning; Science-Based Business; Technological Innovation; Biotechnology Industry; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Tadikonda, Satish. "Atomwise: Strategic Opportunities in AI for Pharma." Harvard Business School Case 824-043, September 2023. (Revised April 2024.)
    • November 2007
    • Case

    Antegren: A Beacon of Hope

    By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
    The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
    Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
    • August 2016
    • Simulation

    BDP Pharmaceuticals

    By: Kevin Schulman, Emma Rasiel and Suresh Balu
    Susan Durham has just been hired as the Chief Financial Officer of Blue Devil Pharmaceuticals (BDP). Her charge is to understand the optimal pathway for the development of a novel molecule, BDP-1, to understand the cost of drug development, the market opportunity, and... View Details
    Keywords: Finance; Entrepreneurship
    Citation
    Purchase
    Related
    Schulman, Kevin, Emma Rasiel, and Suresh Balu. "BDP Pharmaceuticals." Harvard Business School Simulation 317-702, August 2016.
    • July 2016
    • Case

    Blue D Pharmaceuticals

    By: Kevin Schulman, Emma Rasiel and Suresh Balu
    Susan Durham has just been hired as the Chief Financial Officer of Blue Devil Pharmaceuticals (BDP). Her charge is to understand the optimal pathway for the development of a novel molecule, BDP-1, to understand the cost of drug development, the market opportunity, and... View Details
    Keywords: Finance; Entrepreneurship
    Citation
    Educators
    Related
    Schulman, Kevin, Emma Rasiel, and Suresh Balu. "Blue D Pharmaceuticals." Harvard Business School Case 317-014, July 2016.
    • January 2007 (Revised August 2008)
    • Case

    NatuRi Corporation

    By: Robert F. Higgins and Virginia Fuller
    NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from the byproducts of rice bran oil production. With operations split between Chennai, India and Boston, Massachusetts, NatuRi faced several challenges,... View Details
    Keywords: Business Startups; Decision Choices and Conditions; Entrepreneurship; Venture Capital; Equity; Investment Funds; Growth and Development Strategy; Chennai; Boston
    Citation
    Educators
    Purchase
    Related
    Higgins, Robert F., and Virginia Fuller. "NatuRi Corporation." Harvard Business School Case 807-027, January 2007. (Revised August 2008.)
    • ←
    • 23
    • 24
    • …
    • 49
    • 50
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.